In addition to the markers for these subtypes, Helal et al. also assessed the prognostic significance of human epidermal growth factor 2 (HER2) and epidermal growth factor receptor (EGFR) expression in bladder tumors. This evidence concerns the gene EGFR and urinary bladder neoplasm.